Fertiglobe Financial Overview

Reconciliation of Adjusted EBITDA and Adjusted Net Profit 9M 2021 Adjustment in P&L 708.3 202.1 910.4 Reconciliation of reported operating profit to adjusted EBITDA $ million Operating profit as reported Depreciation and amortization EBITDA APM adjustments for: Movement in provisions Insurance recovery Total APM adjustments Adjusted EBITDA Q3 2022 549.2 Q3 2021 311.3 60.1 65.8 9M 2022 1,814.0 184.9 609.3 377.1 1,998.9 (6.4) 5.0 (7.5) (3.0) (3.0) (3.0) (6.4) 2.0 (7.5) 606.3 370.7 2,000.9 902.9 Reconciliation of reported net profit to adjusted net profit $ million Reported net profit attributable to shareholders Adjustments for: Cost of sales Other income Q3 2022 291.6 Q3 2021 137.7 9M 2022 1,077.6 9M 2021 336.2 Adjustment in P&L Adjustments at EBITDA level Accelerated depreciation Forex loss/(gain) on USD exposure Other financial expense Non-controlling interest adjustment Tax effect of adjustments (3.0) (6.4) 2.0 (7.5) 9.2 Depreciation Finance income and expense 39.4 (5.5) 6.4 (11.8) 0.3 10.0 Finance expense Uncertain tax positions/minorities (37.6) 32.4 (6.1) 36.4 0.8 0.8 (2.2) Taxes Total APM adjustments at net profit level (0.1) 20.5 13.1 24.1 Adjusted net profit attributable to shareholders 291.5 158.2 1,090.7 360.3 Fertiglobe An ADNOC and OCI Company 20

View entire presentation